PureTech Health plc (OTCMKTS:PTCHF) Sees Significant Growth in Short Interest

PureTech Health plc (OTCMKTS:PTCHF) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 54,000 shares, an increase of 730.8% from the October 31st total of 6,500 shares. Based on an average daily volume of 25,200 shares, the days-to-cover ratio is presently 2.1 days.

PureTech Health Price Performance

Shares of PTCHF traded down $0.08 on Wednesday, hitting $2.02. The company’s stock had a trading volume of 5,000 shares, compared to its average volume of 32,563. The firm’s fifty day moving average price is $1.97 and its 200-day moving average price is $2.23. PureTech Health has a fifty-two week low of $1.69 and a fifty-two week high of $3.00.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.